Literature DB >> 17239557

Characterization of retinaldehyde dehydrogenase-2 induction in NG2-positive glia after spinal cord contusion injury.

Johanna Kern1, Kirsten Schrage, Guido C Koopmans, Elbert A Joosten, Peter McCaffery, Jörg Mey.   

Abstract

The transcriptional activator retinoic acid (RA) supports axonal regeneration of several neuronal cell populations in vitro, and it has been suggested that its receptor RARbeta2 may be used to support axonal regeneration in the adult mammalian spinal cord. We have previously shown that spinal cord injury induces activity of the RA synthesizing enzyme retinaldehyde dehydrogenase (RALDH)2 in NG2-positive cells. This report quantifies the increase of RALDH2 protein in the injured spinal cord and characterizes the RALDH2/NG2 expressing cells probably as a unique RA synthesizing subpopulation of activated oligodendrocyte precursors or "polydendrocytes". In the uninjured spinal cord low levels of RALDH2 are present in oligodendrocytes as well as in the meninges and in blood vessels. Following injury there is a significant increase in RALDH2 in these latter two tissues and, given that the RALDH2/NG2 positive cells are clustered in the same area, this implies that these are specific foci of RA synthesis. It is presumed that these cells release RA in a paracrine fashion in the region of the wound; however, the RALDH2/NG2-immunoreactive cells expressed the retinoid receptors RARalpha, RARbeta, RXRalpha and RXRbeta, suggesting that RA also serves an autocrine function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17239557     DOI: 10.1016/j.ijdevneu.2006.11.006

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  12 in total

Review 1.  Oligodendrocyte fate after spinal cord injury.

Authors:  Akshata Almad; F Rezan Sahinkaya; Dana M McTigue
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 2.  Physiological insights into all-trans-retinoic acid biosynthesis.

Authors:  Joseph L Napoli
Journal:  Biochim Biophys Acta       Date:  2011-05-19

3.  Metabolic disturbances of the vitamin A pathway in human diaphragmatic hernia.

Authors:  Karen Coste; Leonardus W J E Beurskens; Pierre Blanc; Denis Gallot; Amélie Delabaere; Loïc Blanchon; Dick Tibboel; André Labbé; Robbert J Rottier; Vincent Sapin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-01-15       Impact factor: 5.464

4.  Nuclear Receptors and Neuroinflammation in Schizophrenia.

Authors:  Shan-Yuan Tsai; Vibeke S Catts; Janice M Fullerton; Susan M Corley; Stuart G Fillman; Cynthia Shannon Weickert
Journal:  Mol Neuropsychiatry       Date:  2018-01-16

5.  RAR/RXR and PPAR/RXR Signaling in Spinal Cord Injury.

Authors:  Sabien van Neerven; Jörg Mey
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

6.  Effects of electroacupuncture and the retinoid X receptor (RXR) signalling pathway on oligodendrocyte differentiation in the demyelinated spinal cord of rats.

Authors:  Xiao-Hua Yang; Ying Ding; Wen Li; Rong-Yi Zhang; Jin-Lang Wu; Eng-Ang Ling; Wutian Wu; Yuan-Shan Zeng
Journal:  Acupunct Med       Date:  2016-10-24       Impact factor: 2.267

7.  Retinoic acid synthesis by NG2 expressing cells promotes a permissive environment for axonal outgrowth.

Authors:  Maria B Goncalves; Yue Wu; Diogo Trigo; Earl Clarke; Tony Malmqvist; John Grist; Carl Hobbs; Thomas P Carlstedt; Jonathan P T Corcoran
Journal:  Neurobiol Dis       Date:  2017-12-20       Impact factor: 5.996

8.  Retinoic Acid Is Required for Oligodendrocyte Precursor Cell Production and Differentiation in the Postnatal Mouse Corpus Callosum.

Authors:  Vivianne E Morrison; Victoria N Smith; Jeffrey K Huang
Journal:  eNeuro       Date:  2020-01-22

Review 9.  Towards retinoid therapy for Alzheimer's disease.

Authors:  K Shudo; H Fukasawa; M Nakagomi; N Yamagata
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

10.  Col1a1+ perivascular cells in the brain are a source of retinoic acid following stroke.

Authors:  Kathleen K Kelly; Amber M MacPherson; Himmat Grewal; Frank Strnad; Jace W Jones; Jianshi Yu; Keely Pierzchalski; Maureen A Kane; Paco S Herson; Julie A Siegenthaler
Journal:  BMC Neurosci       Date:  2016-07-15       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.